文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
T. Mantaian
发表
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
M. Amonkar, Jan Mikelson, M. Madin-Warburton, 2024, Journal of medical economics.